Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Medipharm Labs Corp.
MMJ Group Holdings Ltd (MMJJF) MediPharm Labs (MLCPF) Management Team Increase Shareholdings
Published Jan 9 2019
4 min read

MMJ Group Holdings Ltd (MMJJF) MediPharm Labs (MLCPF) Management Team Increase Shareholdings

MMJ Group Holdings Ltd (MMJJF) MediPharm Labs (MLCPF) Management Team Increase Shareholdings
Perth, Australia (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to attach a copy of a news release by MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) (OTCMKTS:MLCPF) announcing that members of its management team and board have increased their combined shareholding in the company (by exercising share options) to over 39%.

MMJ owns approximately 4.4 million shares for a 4.3% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.

To view the news release, please visit:
http://abnnewswire.net/lnk/10N56328



About MMJ Group Holdings Ltd:

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/



Source:

MMJ Group Holdings Ltd



Contact:

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au